TBA (last known deadline was June 15, 2012)
The goal of the Awards Program is to support innovative drug discovery research that will lead to improved therapies for individuals suffering from Alzheimer's disease. As steward of the Thome Memorial Foundation, Bank of America, N.A. works with The Medical Foundation division Scientific Review Committees to help select the most qualified candidates. Examples of funding areas include the design, synthesis, and development of target compounds or the modification of existing compounds to improve drug effectiveness and safety as well as other approaches within the field of medicinal chemistry. Researchers dedicated to the validation and testing of target compounds, small molecule therapies, nanotechnologies, or similar techniques are also encouraged to apply. Basic research or new target discovery, genetic studies, biomarker research, neuroimaging, and clinical studies are currently outside the scope of this Program.